ArticleTranslational lung cancer research2020

EGFR tyrosine kinase inhibitors (TKIs) for adjuvant therapy of early-stage non-small cell lung cancer (NSCLC): ready for the clinic?

Conor E Steuer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.